However, post-market reports document AFib episodes in some GLP-1 users, likely driven by rapid weight loss, electrolyte shifts, or unmasking of underlying predisposition rather than the drug's mechanism
What This Article Does Not Claim This article does not claim that RxSpan MD guarantees prescription approval, guarantees weight loss, provides FDA-approved compounded medications, operates as a pharmacy, replaces in-person medical care, or is appropriate for every consumer
While there is some evidence to suggest that GLP-1 agonists may have health benefits beyond their approved use for type 2 diabetes and obesity, non-diabetics should not take these medications without a prescription and guidance from a healthcare professional
When translated into the number of patients needing treatment, substituting semaglutide for other glucose-lowering agents would prevent one additional seizure for every 70 patients treated, and substituting semaglutide for SGLT2 inhibitors would prevent one additional seizure for every 131 patients treated
Is the GLP-1 cleavage (by membrane-bound DPP-4) icon customizable in BioRender
In addition to weight loss, Semaglutide treatment may improve various health markers, such as blood sugar, cholesterol, and blood pressure